<DOC>
	<DOC>NCT02804828</DOC>
	<brief_summary>The purpose of this study is to develop preliminary evidence, such as effect size and variance estimates, to guide successful conduct of a properly-powered clinical trial to assess the benefit of a mitochondrial cocktail plus individualized correction of citric acid cycle (CAC) intermediates and amino acid (AA) abnormalities as part of a mitochondrial/oxidative stress treatment approach in Gulf War Illness (GWI).</brief_summary>
	<brief_title>Mitochondrial Cocktail for Gulf War Illness</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<mesh_term>Persian Gulf Syndrome</mesh_term>
	<mesh_term>Cod Liver Oil</mesh_term>
	<criteria>Meet symptom criteria for Gulf War illness with BOTH the Centers for Disease Control and Prevention (CDC) Criteria (persistent symptoms in at least 2 of 3 designated symptom domains of fatigue/sleep, mood/cognition, and musculoskeletal) and Kansas Criteria (score a moderate or severe rating in at least 3 of the 6 symptom domains of fatigue, pain, neurological/cognitive/mood, skin, GI and respiratory). Have conditions like multiple sclerosis or lupus that can produce similar symptoms and be confused for Gulf War illness.</criteria>
	<gender>All</gender>
	<minimum_age>43 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>